Beverly C. Cordova

2.1k citations

34 papers · 1.8k indexed · h-index 20

Co-authors: Ronald M. Klabe Susan Erickson‐Viitanen Lee T. Bacheler James D. Rodgers E. Knight George L. Trainor Mona Patel Robert J. McHugh
Topics: HIV/AIDS drug development and treatment (29 papers)HIV Research and Treatment (19 papers)Biochemical and Molecular Research (11 papers)
Cited by: Virology Organic Chemistry Infectious Diseases
Journals: Proceedings of the National Academy of Sciences Journal of Biological Chemistry The Journal of Immunology
Partner nations: United States Germany United Kingdom

In The Last Decade

Beverly C. Cordova

34 papers receiving 1.7k citations

Peers

Countries citing papers authored by Beverly C. Cordova

Since Specialization

Citations

This map shows the geographic impact of Beverly C. Cordova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beverly C. Cordova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beverly C. Cordova more than expected).

Fields of papers citing papers by Beverly C. Cordova

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Beverly C. Cordova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beverly C. Cordova. The network helps show where Beverly C. Cordova may publish in the future.

Co-authorship network of co-authors of Beverly C. Cordova

This figure shows the co-authorship network connecting the top 25 collaborators of Beverly C. Cordova. A scholar is included among the top collaborators of Beverly C. Cordova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Beverly C. Cordova. Beverly C. Cordova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Synthesis, antiviral activity and pharmacokinetics of P1/P1′ substituted 3-aminoindazole cyclic urea HIV protease inhibitors 2003 ·Bioorganic & Medicinal Chemistry Letters ·Robert F. Kaltenbach,Mona Patel,Robert E. Waltermire,(unknown),(unknown),Ronald M. Klabe,Sena Garber,Lee T. Bacheler,Beverly C. Cordova,(unknown),Matthew Wright,Susan Erickson‐Viitanen,George L. Trainor	24
2	Drug design with a new transition state analog of the hydrated carbonyl: silicon-based inhibitors of the HIV protease 2001 ·Chemistry & Biology ·(unknown),Scott McN. Sieburth,Athanasios Glekas,(unknown),George L. Trainor,Susan Erickson‐Viitanen,Sena Garber,Beverly C. Cordova,(unknown),Ronald M. Klabe	67
3	Synthesis and Evaluation of Efavirenz (SustivaTM) Analogues as HIV-1 Reverse Transcriptase Inhibitors: Replacement of the Cyclopropylacetylene Side Chain 2001 ·Bioorganic & Medicinal Chemistry Letters ·Anthony J. Cocuzza,Dennis R. Chidester,Beverly C. Cordova,Susan Jeffrey,Rodney L. Parsons,Lee T. Bacheler,Susan Erickson‐Viitanen,George L. Trainor,(unknown)	67
4	Trifluoromethyl-containing 3-alkoxymethyl- and 3-aryloxymethyl-2-pyridinones are potent inhibitors of hIV-1 non-nucleoside reverse transcriptase 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,(unknown),(unknown),Beverly C. Cordova,Ronald M. Klabe,James D. Rodgers,Susan Erickson‐Viitanen	13
5	Synthesis and evaluation of novel quinolinones as HIV-1 reverse transcriptase inhibitors 2001 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert J. McHugh,Beverly C. Cordova,Ronald M. Klabe,Lee T. Bacheler,Susan Erickson‐Viitanen,James D. Rodgers	81
6	Synthesis and biological activities of potential metabolites of the non-nucleoside reverse transcriptase inhibitor Efavirenz 2001 ·Bioorganic & Medicinal Chemistry Letters ·Jay A. Markwalder,David D. Christ,Abdul Mutlib,Beverly C. Cordova,Ronald M. Klabe,Steven P. Seitz	12
7	Novel 2,2-dioxide-4,4-disubstituted-1,3-H-2,1,3-benzothiadiazines as non-nucleoside reverse transcriptase inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Jeffrey W. Corbett,(unknown),Soo S. Ko,James D. Rodgers,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen	13
8	Synthesis and evaluation of quinoxalinones as HIV-1 reverse transcriptase inhibitors 2000 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert J. McHugh,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,George L. Trainor,James D. Rodgers	78
9	Increased antiviral activity of cyclic urea HIV protease inhibitors by modifying the P1/P1′ substituents 1999 ·Bioorganic & Medicinal Chemistry Letters ·Robert F. Kaltenbach,Ronald M. Klabe,Beverly C. Cordova,Steven P. Seitz	8
10	Unsymmetrical cyclic ureas as HIV-1 protease inhibitors: Novel biaryl indazoles as P2/P2′ substituents 1999 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,James D. Rodgers,Robert J. McHugh,Barry L. Johnson,Beverly C. Cordova,Ronald M. Klabe,Lee T. Bacheler,Susan Erickson‐Viitanen,Soo S. Ko	53
11	Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors 1998 ·Chemistry & Biology ·James D. Rodgers,Patrick Y. S. Lam,Barry L. Johnson,Haisheng Wang,Soo S. Ko,Steven P. Seitz,George L. Trainor,Paul Anderson,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Sena Garber,Carol Reid,Matthew Wright,Chong‐Hwan Chang,Susan Erickson‐Viitanen	1
12	The synthesis of symmetrical and unsymmetrical P1/P1′ cyclic ureas as HIV protease inhibitors 1998 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Robert F. Kaltenbach,David A. Nugiel,Robert J. McHugh,Prabhakar K. Jadhav,Lee T. Bacheler,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,Sena Garber,Carol Reid,Steven P. Seitz	19
13	Potent cyclic urea HIV protease inhibitors with 3-aminoindazole P2/P2′ groups 1998 ·Bioorganic & Medicinal Chemistry Letters ·James D. Rodgers,Barry L. Johnson,(unknown),Susan Erickson‐Viitanen,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Chong‐Hwan Chang	34
14	The synthesis and evaluation of cyclic ureas as HIV protease inhibitors: Modifications of the P1/P1′ residues 1998 ·Bioorganic & Medicinal Chemistry Letters ·Mona Patel,Lee T. Bacheler,Marlene M. Rayner,Beverly C. Cordova,Ronald M. Klabe,Susan Erickson‐Viitanen,Steven P. Seitz	16
15	Design and selection of DMP 850 and DMP 851: the next generation of cyclic urea HIV protease inhibitors 1998 ·Chemistry & Biology ·James D. Rodgers,Patrick Y. S. Lam,(unknown),Haisheng Wang,(unknown),Steven P. Seitz,George L. Trainor,Paul Anderson,Ronald M. Klabe,Lee T. Bacheler,Beverly C. Cordova,Sena Garber,Carol Reid,Matthew Wright,(unknown),Susan Erickson‐Viitanen	32
16	Population Dynamics Studies of Wild-Type and Drug-Resistant Mutant HIV in Mixed Infections 1997 ·Virology ·Marlene M. Rayner,Beverly C. Cordova,David A. Jackson	20
17	Design, Synthesis, and Evaluation of Tetrahydropyrimidinones as an Example of a General Approach to Nonpeptide HIV Protease Inhibitors 1997 ·Journal of Medicinal Chemistry ·George V. De Lucca,Jing Liang,Paul E. Aldrich,J. C. CALABRESE,Beverly C. Cordova,Ronald M. Klabe,Marlene M. Rayner,Chong‐Hwan Chang	40
18	A bis-[N-3-(1-hydroxy-1-methyl-ethyl)-benzyl)-cyclic urea as a HIV protease inhibitor 1995 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Gilbert N. Lam,Susan Erickson‐Viitanen,Lee T. Bacheler,Beverly C. Cordova,Ronald M. Klabe,James L. Meek	5
19	DMP 323, a nonpeptide cyclic urea inhibitor of human immunodeficiency virus (HIV) protease, specifically and persistently blocks intracellular processing of HIV gag polyprotein 1994 ·Antimicrobial Agents and Chemotherapy ·Marlene M. Rayner,Beverly C. Cordova,(unknown),Paul E. Aldrich,(unknown),(unknown),Patrick Y. S. Lam	15
20	A 15-kD Interferon-Induced Protein and Its 17-kD Precursor: Expression in Escherichia coli , Purification, and Characterization 1989 ·Journal of Interferon Research ·(unknown),Milton C. Hillman,Beverly C. Cordova,(unknown),(unknown),Dale C. Blomstrom,Ernest Knight	8

About Beverly C. Cordova

Beverly C. Cordova is a scholar working on Virology, Infectious Diseases and Organic Chemistry, having authored 34 papers that have together received 1.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (29 papers), HIV Research and Treatment (19 papers) and Biochemical and Molecular Research (11 papers). The work is most often cited by research in Virology (499 citations), Organic Chemistry (889 citations) and Infectious Diseases (557 citations). Beverly C. Cordova has collaborated with scholars based in United States, Germany and United Kingdom. Frequent co-authors include Ronald M. Klabe, Susan Erickson‐Viitanen, Lee T. Bacheler, James D. Rodgers, E. Knight, George L. Trainor, Mona Patel, Robert J. McHugh, Susan Jeffrey and Soo S. Ko. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact